BG106623A - Метод за приложение на фосфодиестераза 4 инхибитор - Google Patents
Метод за приложение на фосфодиестераза 4 инхибитор Download PDFInfo
- Publication number
- BG106623A BG106623A BG106623A BG10662302A BG106623A BG 106623 A BG106623 A BG 106623A BG 106623 A BG106623 A BG 106623A BG 10662302 A BG10662302 A BG 10662302A BG 106623 A BG106623 A BG 106623A
- Authority
- BG
- Bulgaria
- Prior art keywords
- drug
- release
- combination
- administered
- plasma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16247799P | 1999-10-29 | 1999-10-29 | |
US16264199P | 1999-11-01 | 1999-11-01 | |
US17981700P | 2000-02-02 | 2000-02-02 | |
PCT/US2000/029453 WO2001032165A1 (en) | 1999-10-29 | 2000-10-26 | Method for administering a phosphodiesterase 4 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
BG106623A true BG106623A (bg) | 2003-02-28 |
Family
ID=27388757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG106623A BG106623A (bg) | 1999-10-29 | 2002-04-17 | Метод за приложение на фосфодиестераза 4 инхибитор |
Country Status (29)
Country | Link |
---|---|
US (1) | US20030212112A1 (no) |
EP (1) | EP1225884A4 (no) |
JP (1) | JP2003513038A (no) |
KR (1) | KR20020050249A (no) |
CN (1) | CN1387433A (no) |
AP (1) | AP2002002446A0 (no) |
AR (1) | AR026254A1 (no) |
AU (1) | AU772909B2 (no) |
BG (1) | BG106623A (no) |
BR (1) | BR0015039A (no) |
CA (1) | CA2389293A1 (no) |
CO (1) | CO5271676A1 (no) |
CZ (1) | CZ20021443A3 (no) |
DZ (1) | DZ3249A1 (no) |
EA (1) | EA200200502A1 (no) |
HK (1) | HK1049105A1 (no) |
HU (1) | HUP0203682A3 (no) |
IL (1) | IL148813A0 (no) |
MA (1) | MA25562A1 (no) |
MX (1) | MXPA02004220A (no) |
NO (1) | NO20021937L (no) |
NZ (1) | NZ518002A (no) |
OA (1) | OA12078A (no) |
PE (1) | PE20011004A1 (no) |
PL (1) | PL355262A1 (no) |
SK (1) | SK7292002A3 (no) |
TR (1) | TR200201150T2 (no) |
UY (1) | UY26422A1 (no) |
WO (1) | WO2001032165A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR029984A1 (es) * | 2000-07-27 | 2003-07-23 | Smithkline Beecham Corp | Metodo para reducir las exacerbaciones asociadas copd ambito |
DE10207160A1 (de) * | 2002-02-20 | 2003-12-18 | Altana Pharma Ag | Darreichungsform enthaltend PDE 4-Hemmer als Wirkstoff |
MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
ES2354971T3 (es) * | 2002-05-28 | 2011-03-21 | Nycomed Gmbh | Uso oftalmológico de roflumilast para el tratamiento de enfermedades de los ojos. |
US6822114B1 (en) | 2002-10-08 | 2004-11-23 | Albemarle Corporation | Process for production of fluoroalkoxy-substituted benzamides and their intermediates |
US7470791B2 (en) | 2003-03-10 | 2008-12-30 | Nycomed Gmbh | Process for the preparation of roflumilast |
CA2520779A1 (en) * | 2003-03-31 | 2004-11-11 | Kyowa Hakko Kogyo Co., Ltd. | Agent for intra-airway administration |
US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
ES2421916T3 (es) | 2005-03-16 | 2013-09-06 | Nycomed Gmbh | Forma farmacéutica de sabor enmascarado que contiene roflumilast |
EP2506711B1 (en) * | 2009-12-03 | 2019-04-03 | OPKO Health, Inc. | Hypersulfated disaccharide formulations |
PT2797581T (pt) * | 2011-12-27 | 2020-06-18 | Amgen Europe Gmbh | Formulações de (+)-2-[1-(3-etoxi-4-metoxi-fenil)-2-metanossulfonil-etil]-4-acetilaminoisoindolino-1,3-diona |
CN103536582A (zh) * | 2013-10-12 | 2014-01-29 | 云南龙海天然植物药业有限公司 | 罗氟司特干粉吸入剂 |
WO2019147824A1 (en) | 2018-01-26 | 2019-08-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor |
EP3883635A1 (en) | 2018-11-19 | 2021-09-29 | Progenity, Inc. | Methods and devices for treating a disease with biotherapeutics |
CN115666704A (zh) | 2019-12-13 | 2023-01-31 | 比奥拉治疗股份有限公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684516A (en) * | 1983-08-01 | 1987-08-04 | Alra Laboratories, Inc. | Sustained release tablets and method of making same |
AR028986A1 (es) * | 1999-02-23 | 2003-06-04 | Smithkline Beecham Corp | USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA |
AR035987A1 (es) * | 1999-03-01 | 2004-08-04 | Smithkline Beecham Corp | Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio |
-
2000
- 2000-10-26 NZ NZ518002A patent/NZ518002A/en unknown
- 2000-10-26 CA CA002389293A patent/CA2389293A1/en not_active Abandoned
- 2000-10-26 EA EA200200502A patent/EA200200502A1/ru unknown
- 2000-10-26 BR BR0015039-8A patent/BR0015039A/pt not_active IP Right Cessation
- 2000-10-26 CN CN00815150A patent/CN1387433A/zh active Pending
- 2000-10-26 EP EP00975385A patent/EP1225884A4/en not_active Withdrawn
- 2000-10-26 OA OA1200200126A patent/OA12078A/en unknown
- 2000-10-26 PL PL00355262A patent/PL355262A1/xx unknown
- 2000-10-26 AP APAP/P/2002/002446A patent/AP2002002446A0/en unknown
- 2000-10-26 DZ DZ003249A patent/DZ3249A1/fr active
- 2000-10-26 MX MXPA02004220A patent/MXPA02004220A/es unknown
- 2000-10-26 HU HU0203682A patent/HUP0203682A3/hu unknown
- 2000-10-26 WO PCT/US2000/029453 patent/WO2001032165A1/en not_active Application Discontinuation
- 2000-10-26 TR TR2002/01150T patent/TR200201150T2/xx unknown
- 2000-10-26 AR ARP000105644A patent/AR026254A1/es not_active Application Discontinuation
- 2000-10-26 CZ CZ20021443A patent/CZ20021443A3/cs unknown
- 2000-10-26 KR KR1020027005448A patent/KR20020050249A/ko not_active Application Discontinuation
- 2000-10-26 IL IL14881300A patent/IL148813A0/xx unknown
- 2000-10-26 AU AU13445/01A patent/AU772909B2/en not_active Ceased
- 2000-10-26 JP JP2001534370A patent/JP2003513038A/ja not_active Withdrawn
- 2000-10-26 CO CO00081570A patent/CO5271676A1/es not_active Application Discontinuation
- 2000-10-26 SK SK729-2002A patent/SK7292002A3/sk unknown
- 2000-10-27 PE PE2000001157A patent/PE20011004A1/es not_active Application Discontinuation
- 2000-10-30 UY UY26422A patent/UY26422A1/es not_active Application Discontinuation
-
2002
- 2002-04-17 BG BG106623A patent/BG106623A/bg unknown
- 2002-04-24 NO NO20021937A patent/NO20021937L/no not_active Application Discontinuation
- 2002-04-26 MA MA26618A patent/MA25562A1/fr unknown
- 2002-12-19 HK HK02109231.8A patent/HK1049105A1/zh unknown
-
2003
- 2003-05-02 US US10/429,666 patent/US20030212112A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR026254A1 (es) | 2003-02-05 |
MXPA02004220A (es) | 2002-10-17 |
HUP0203682A3 (en) | 2003-10-28 |
UY26422A1 (es) | 2001-07-31 |
EP1225884A4 (en) | 2005-06-15 |
EP1225884A1 (en) | 2002-07-31 |
US20030212112A1 (en) | 2003-11-13 |
NO20021937D0 (no) | 2002-04-24 |
PE20011004A1 (es) | 2001-09-28 |
NO20021937L (no) | 2002-05-30 |
TR200201150T2 (tr) | 2002-09-23 |
DZ3249A1 (fr) | 2001-05-10 |
PL355262A1 (en) | 2004-04-05 |
BR0015039A (pt) | 2002-06-25 |
AU1344501A (en) | 2001-05-14 |
OA12078A (en) | 2003-05-28 |
CA2389293A1 (en) | 2001-05-10 |
SK7292002A3 (en) | 2002-12-03 |
HK1049105A1 (zh) | 2003-05-02 |
JP2003513038A (ja) | 2003-04-08 |
CN1387433A (zh) | 2002-12-25 |
AU772909B2 (en) | 2004-05-13 |
CO5271676A1 (es) | 2003-04-30 |
HUP0203682A2 (hu) | 2003-04-28 |
AP2002002446A0 (en) | 2002-03-31 |
EA200200502A1 (ru) | 2002-10-31 |
NZ518002A (en) | 2004-01-30 |
WO2001032165A1 (en) | 2001-05-10 |
MA25562A1 (fr) | 2002-10-01 |
KR20020050249A (ko) | 2002-06-26 |
IL148813A0 (en) | 2002-09-12 |
CZ20021443A3 (cs) | 2003-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG106623A (bg) | Метод за приложение на фосфодиестераза 4 инхибитор | |
JP5921513B2 (ja) | ナルトレキソンの徐放型配合物 | |
US6544554B1 (en) | Regulated release preparations | |
US10213398B2 (en) | Methods for alleviating statin myopathy | |
CN113453677A (zh) | 用于治疗急性心房颤动的舒卡定施用 | |
KR20010093845A (ko) | 피브레이트와 세리바스타틴의 복합제제 | |
CA2555316A1 (en) | Combined pharmaceutical composition | |
US20060083783A1 (en) | Treating metabolic syndrome with fenofibrate | |
JP2002536331A (ja) | (e)−7−[4−(4−フルオロフェニル)−6−イソプロピル−2−[メチル(メチルスルホニル)アミノ]ピリミジン−5−イル](3r,5s)−3,5−ジヒドロキシヘプツ−6−エン酸と、p450アイソザイム3a4の阻害剤、誘導剤又は基質を含んでなる薬物の組み合わせ | |
TW201902471A (zh) | 賈卡賓尼(gemcabene)、其醫藥上可接受之鹽、彼等之組成物及使用彼等之方法 | |
Dulac et al. | Bioequivalence of a new sustained‐release formulation of sodium valproate, valproate modified‐release granules, compared with existing sustained‐release formulations after once‐or twice‐daily administration | |
CZ20013025A3 (cs) | Prostředek s řízeným uvolňováním pro léčbu COPD | |
KR20030019620A (ko) | Copd와 관련된 증상 악화의 감소 방법 | |
WO2005044258A1 (en) | Simvastatin formulations and methods of making same | |
AU2018291076B2 (en) | Combination and uses and treatments thereof | |
KR20240040767A (ko) | His 저감반응자의 치료 | |
WO2005013940A1 (en) | Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin | |
RU2336076C2 (ru) | Пероральное лекарственное средство для восполнения дефицита магния в организме | |
US5627152A (en) | Method for increasing bodyweight | |
Reddy et al. | Formulation and Evaluation of Oral Controlled Release Matrix Tablets of Propranolol Hydrochloride | |
JP2016514125A (ja) | バルサルタン及びロスバスタチンカルシウムを含む複合製剤及びその製造方法 | |
WO1998015290A1 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING HMG-CoA REDUCTASE INHIBITORS, IN PARTICULAR FLUVASTATIN | |
ZA200203349B (en) | Method for administering a phosphodiesterase 4 inhibitor. | |
WO2020053218A1 (en) | Treatment of psoriasis | |
WO2020053219A1 (en) | Treatment of psoriasis |